Current Report Filing (8-k)
2022年7月6日 - 4:55AM
Edgar (US Regulatory)
0001087022
false
false
false
false
false
0001087022
2022-07-05
2022-07-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section
13 or 15(d) of the
Securities Exchange
Act of 1934
Date of Report (Date
of earliest event reported): July 5, 2022
ALR
TECHNOLOGIES INC.
(Exact Name of Registrant
as Specified in Charter)
Nevada |
|
000-30414 |
|
88-0225807 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
7400
Beaufont Springs Drive
Suite
300
Richmond,
Virginia 23225
(Address
of Principal Executive Offices) (Zip Code)
(804)
554-3500
Registrant’s
telephone number, including area code
(Former Name or Former
Address
if Changed Since Last
Report)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
[ ] |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
[ ] |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
[ ] |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
[ ]
|
Pre-commencement communications
pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of
the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common
Shares |
|
ALRT |
|
OTC US |
Item
1.01 Entry into a Material Definitive Agreement.
On
June 28, 2022, ALR Technologies SG Pte. Ltd. (the “ALRS”), an affiliate company of ALR Technologies Inc. (the “Company”)
entered into a Manufacturing and Supply Agreement (the “Supply Agreement”) with Infinovo Medical Co., Ltd. (“Infinovo”).
Pursuant to the Supply Agreement, Infinovo will manufacture and supply certain continuous glucose monitoring components necessary to
the Company’s diabetes management platform for animal health, known as “GluCurve.” The term of the Supply Agreement
continues for three (3) years from August 1, 2022, unless earlier terminated in accordance with the terms of the Supply Agreement. The
Supply Agreement, however, will not become effective unless (1) ALRS enters into a binding distribution agreement for the sale and distribution
of GluCurve by July 31, 2022, and (2) ALRS and Infinovo enter into a quality agreement by July 31, 2022. There can be no assurance that
the two conditions to effectiveness of the Supply Agreement will be satisfied. If the conditions are met and the agreement becomes effective,
the Supply Agreement will automatically renew for additional one (1) year terms unless ALRS or Infinovo provides written notice of its
intent to terminate the Supply Agreement. The Supply Agreement provides for customary reasons to terminate the Supply Agreement for cause
with immediate effect.
The
Supply Agreement also includes customary indemnification, intellectual property protection, confidentiality, remedies, and representations
and warranties terms, as well as certain quality requirements.
The
above description of the Supply Agreement and the transactions contemplated thereby does not purport to be complete and is qualified
in its entirety by reference to the full text of the Supply Agreement, which is filed as Exhibit 10.1 to this Current Report on Form
8-K and which is incorporated herein by reference.
| Item 7.01 | Regulation
FD Disclosure. |
On
June 29, 2022, the Company issued a press release titled “ALR Technologies Completes Definitive Manufacturing Agreement with
Infinovo Medical for the GluCurve Pet CGM Hardware.”
A
copy of this press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
| Item 9.01 | Financial
Statements and Exhibits. |
(d) Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
July 5, 2022 |
ALR
TECHNOLOGIES INC. |
|
|
|
|
|
|
By: |
/s/
Sidney Chan |
|
|
Name: Sidney
Chan |
|
Title: |
Chairman and CEO |
|
ALR Technologies (QB) (USOTC:ALRT)
過去 株価チャート
から 5 2024 まで 6 2024
ALR Technologies (QB) (USOTC:ALRT)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about ALR Technologies Inc (QB) (その他OTC): 0 recent articles
その他のAlr Technologies Inc.ニュース記事